Your browser doesn't support javascript.
loading
A Review of the Efficacy of FDA-Approved B. anthracis Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical Models.
Couse, Zoe; Cui, Xizhong; Li, Yan; Moayeri, Mahtab; Leppla, Stephen; Eichacker, Peter Q.
Afiliación
  • Couse Z; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.
  • Cui X; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.
  • Li Y; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.
  • Moayeri M; National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Leppla S; National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Eichacker PQ; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.
Toxins (Basel) ; 13(1)2021 01 13.
Article en En | MEDLINE | ID: mdl-33450877

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Choque Séptico / Toxinas Bacterianas / Antitoxinas / Carbunco / Antibacterianos / Antígenos Bacterianos Tipo de estudio: Clinical_trials País/Región como asunto: America do norte Idioma: En Revista: Toxins (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Choque Séptico / Toxinas Bacterianas / Antitoxinas / Carbunco / Antibacterianos / Antígenos Bacterianos Tipo de estudio: Clinical_trials País/Región como asunto: America do norte Idioma: En Revista: Toxins (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos